Literature DB >> 16077938

Cancer cachexia results in an increase in TNF-alpha receptor gene expression in both skeletal muscle and adipose tissue.

Maite Figueras1, Sílvia Busquets, Neus Carbó, Vanessa Almendro, Josep M Argilés, Francisco J López-Soriano.   

Abstract

The mRNA content of both TNF-alpha and its receptors (TNFR1 and TNFR2) in skeletal muscle and adipose tissue from cachectic rats has been assessed. The implantation of the Yoshida AH-130 ascites hepatoma resulted in substantial decrease in skeletal muscle TNF-alpha expression as early as at day 2 following tumour implantation. However, the mRNA content for the two receptors followed a different pattern, being significantly increased at day 7. In adipose tissue the expression of the TNF-alpha gene was significantly increased at all the time points studied, whereas TNF-alpha receptors expression followed a similar pattern to that observed in skeletal muscle. Western blot analysis indicated that the TNFR1 protein followed an identical pattern to that observed in the mRNA content both in muscle and adipose tissue. It is concluded that, during experimental cancer cachexia, the contribution of muscle-produced TNF-alpha is decreased; however, significant changes were observed in relation with TNF-alpha receptors at the skeletal muscle level that could possibly be related to the muscle wasting process associated with tumour growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077938

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  12 in total

Review 1.  Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies.

Authors:  Kimberlee Burckart; Sorin Beca; Randall J Urban; Melinda Sheffield-Moore
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

2.  Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma.

Authors:  Biswajit Chakraborty; Ramkrishna Pal; Mohammed Ali; Leichombam Mohindro Singh; Dewan Shahidur Rahman; Sujit Kumar Ghosh; Mahuya Sengupta
Journal:  Cell Mol Immunol       Date:  2015-05-04       Impact factor: 11.530

Review 3.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

4.  A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9).

Authors:  Aminah Jatoi; Howard L Ritter; Amylou Dueck; Phuong L Nguyen; Daniel A Nikcevich; Ronnie F Luyun; Bassam I Mattar; Charles L Loprinzi
Journal:  Lung Cancer       Date:  2009-08-08       Impact factor: 5.705

Review 5.  Cardiac Complications: The Understudied Aspect of Cancer Cachexia.

Authors:  Vivek Bora; Bhoomika Patel
Journal:  Cardiovasc Toxicol       Date:  2022-02-16       Impact factor: 3.231

6.  Protective effect of pantoprazole against sepsis-induced acute lung and kidney injury in rats.

Authors:  Xi-Xiang Yan; Ai-Dong Zheng; Zhen-En Zhang; Guo-Cui Pan; Wen Zhou
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

7.  Protein kinase Cepsilon inhibits UVR-induced expression of FADD, an adaptor protein, linked to both Fas- and TNFR1-mediated apoptosis.

Authors:  Moammir Hasan Aziz; Kaitlin Elizabeth Sundling; Nancy Ellen Dreckschmidt; Ajit Kumar Verma
Journal:  J Invest Dermatol       Date:  2009-02-05       Impact factor: 8.551

8.  l-carnitine and cancer cachexia: Clinical and experimental aspects.

Authors:  Renata Silvério; Alessandro Laviano; Filippo Rossi Fanelli; Marília Seelaender
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-01-26       Impact factor: 12.910

Review 9.  Managing Patients With Myelofibrosis in the Era of Janus Kinase Inhibitors.

Authors:  Emily A Knight; Sylvia Osunsuyi-Fagbemi; Jessica Neely
Journal:  J Adv Pract Oncol       Date:  2015-11-01

10.  Notch Signaling Mediates Skeletal Muscle Atrophy in Cancer Cachexia Caused by Osteosarcoma.

Authors:  Xiaodong Mu; Rashmi Agarwal; Daniel March; Adam Rothenberg; Clifford Voigt; Jessica Tebbets; Johnny Huard; Kurt Weiss
Journal:  Sarcoma       Date:  2016-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.